What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - Common Stock in Q1 2026?

63 institutional investors reported PCVX - Vaxcyte, Inc. - Common Stock for Q1 2026. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - Common Stock (PCVX)

CUSIP: 92243G108

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock
Shares outstanding: 144,176,004
Total 13F shares: 3,932,730
Share change: +715,190
Total reported value: $228,530,409
Price per share: $58.11
Number of holders: 63
Value change: +$42,422,364
Number of buys: 30
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 92243G108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F 13D/G	Company	10% from 13D/G	13,834,514	$638,324,485	—	31 Dec 2025	13F 13D/G
JANUS HENDERSON GROUP PLC	13F 13D/G	Company	10% from 13D/G	13,387,188	$617,730,753	—	31 Dec 2025	13F 13D/G
VANGUARD GROUP INC	13F	Company	8.5%	12,193,986	$562,630,515	—	31 Dec 2025	13F
T. Rowe Price Investment Management, Inc.	13F 13D/G	Company	8.6% from 13D/G	11,296,333	$521,213,000	—	31 Dec 2025	13F 13D/G
RA CAPITAL MANAGEMENT, L.P.	13F 13D/G	Company	9.9% from 13D/G	10,724,599	$494,832,998	—	31 Dec 2025	13F 13D/G
BlackRock, Inc.	13F 13D/G	Company	7.6% from 13D/G	10,246,378	$472,767,877	—	31 Dec 2025	13F 13D/G
VANGUARD CAPITAL MANAGEMENT LLC	13D/G	Vanguard Capital Management	5%	7,252,053	$421,416,800	$0	31 Mar 2026	13D/G
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4.1%	5,966,310	$275,285,543	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	3.5%	4,980,005	$229,777,431	—	31 Dec 2025	13F
Paradigm Biocapital Advisors LP	13F	Company	2.8%	4,068,020	$187,698,443	—	31 Dec 2025	13F
Deep Track Capital, LP	13F	Company	2.8%	4,000,000	$184,560,000	—	31 Dec 2025	13F
D. E. Shaw & Co., Inc.	13F	Company	2.5%	3,631,053	$167,536,785	—	31 Dec 2025	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	2.5%	3,539,717	$163,322,542	—	31 Dec 2025	13F
Kynam Capital Management, LP	13F	Company	2%	2,922,335	$134,836,537	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2%	2,866,305	$132,271,037	—	31 Dec 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.2%	1,725,000	$79,591,500	—	31 Dec 2025	13F
Caligan Partners LP	13F	Company	1.2%	1,704,815	$78,660,164	—	31 Dec 2025	13F
Polar Capital Holdings Plc	13F	Company	1.2%	1,672,783	$77,182,208	—	31 Dec 2025	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.95%	1,372,425	$63,323,690	—	31 Dec 2025	13F
MAVERICK CAPITAL LTD	13F	Company	0.94%	1,354,237	$62,484,495	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.9%	1,293,830	$59,697,316	—	31 Dec 2025	13F
NORGES BANK	13F	Company	0.85%	1,228,939	$56,703,245	—	31 Dec 2025	13F
Eversept Partners, LP	13F	Company	0.83%	1,197,722	$55,262,893	—	31 Dec 2025	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.82%	1,175,339	$54,232,000	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.76%	1,093,593	$50,458,382	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0.75%	1,085,519	$50,085,850	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.75%	1,078,120	$49,744,457	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.72%	1,034,180	$47,717,065	—	31 Dec 2025	13F
Aberdeen Group plc	13F	Company	0.68%	979,765	$45,206,357	—	31 Dec 2025	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.64%	917,115	$42,312,560	—	31 Dec 2025	13F
Novo Holdings A/S	13F	Company	0.64%	916,160	$42,271,622	—	31 Dec 2025	13F
Pictet Asset Management Holding SA	13F	Company	0.61%	881,435	$40,669,411	—	31 Dec 2025	13F
Capital Research Global Investors	13F	Company	0.58%	842,978	$38,895,005	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.58%	835,387	$38,544,817	—	31 Dec 2025	13F
Saturn V Capital Management LP	13F	Company	0.55%	798,940	$36,863,092	—	31 Dec 2025	13F
Grant Pickering	3/4/5	CHIEF EXECUTIVE OFFICER, Director	— mixed-class rows	808,852 mixed-class rows	$35,551,596	—	09 Mar 2026	3/4/5
Trails Edge Capital Partners, LP	13F	Company	0.51%	737,470	$34,026,866	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.49%	701,634	$32,373,393	—	31 Dec 2025	13F
JENNISON ASSOCIATES LLC	13F	Company	0.47%	677,553	$31,262,296	—	31 Dec 2025	13F
Logos Global Management LP	13F	Company	0.45%	650,000	$29,991,000	—	31 Dec 2025	13F
Soleus Capital Management, L.P.	13F	Company	0.42%	608,958	$28,097,322	—	31 Dec 2025	13F
BROWN ADVISORY INC	13F	Company	0.39%	566,925	$26,157,919	—	31 Dec 2025	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.38%	549,514	$25,354,577	—	31 Dec 2025	13F
Assenagon Asset Management S.A.	13F	Company	0.38%	544,728	$25,133,750	—	31 Dec 2025	13F
Ensign Peak Advisors, Inc	13F	Company	0.37%	527,688	$24,347,524	—	31 Dec 2025	13F
FEDERATED HERMES, INC.	13F	Company	0.36%	523,489	$24,153,783	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.35%	497,740	$22,965,724	—	31 Dec 2025	13F
Jeff Fairman	3/4/5	VP, Research	— mixed-class rows	369,054 mixed-class rows	$22,935,618	—	30 Dec 2022	3/4/5
EcoR1 Capital, LLC	13F	Company	0.31%	450,000	$20,763,000	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.31%	449,363	$20,733,624	—	31 Dec 2025	13F

Institutional Holders of Vaxcyte, Inc. - Common Stock (PCVX) as of Q1 2026

As of 31 Mar 2026, Vaxcyte, Inc. - Common Stock (PCVX) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,932,730 shares. The largest 10 holders included Assenagon Asset Management S.A., Aberdeen Group plc, Pictet Asset Management Holding SA, Nuveen, LLC, Candriam S.C.A., BANQUE PICTET & CIE SA, Handelsbanken Fonder AB, PROFUND ADVISORS LLC, Police & Firemen's Retirement System of New Jersey, and ARIZONA STATE RETIREMENT SYSTEM. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

292

Q1 2026 holders

Holder diff

-229

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.